Coming up next, the third episode of Stäubli Pharma Impulses!
The Application of High-Performance Robotics in innovative Cell Drug and other Biopharma Manufacturing:
“How do Robotics improve efficiency of Cell Therapy Manufacturing?”
In partnership with Innovel Intelligent Technology (Suzhou) Co. Ltd., China
Register now. Select the time zone that suits you. Both sessions are in English.
We look forward to seeing you.
Broadcasting times
Europe - Asia Pacific
30th March 2022 - 60 min
UTC+2h | 09:00-10:00 AM
Europe - Americas
30th March 2022 - 60 min
UTC+2h | 04:00-05:00 PM
Registration
Speakers
"Cell and Gene Therapy (CGT) offers a revolutionary approach for the treatment and prevention of human diseases, triggering demand on GMP-compliant cell manufacturing solutions. An intelligent and robot-integrated system is our answer to the market."
James CHEN
Founder and Chief Engineer,
Innovel Intelligent Technology (Suzhou) Co. Ltd., China
"The future success of market players, both established and new, can only be assured if their production structures meet the demands of a rapidly changing industry. Cell and gene therapy are the innovative treatments for life threatening diseases such as cancer. The commercialization and manufacturing of cells becomes a big challenge for bio-pharmaceutical companies. It needs the efforts from the whole industrial chain, including the equipment and consumable suppliers."
Rudolf M. WEISS
Global Head of Pharma Robotics,
Stäubli Robotics